Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Merelli

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
Nature Biotechnology|January 25, 2024
Author Correction: Genotoxic effects of base and prime editing in human hematopoietic stem cellsMartina Fiumara, Samuele Ferrari, Attya Omer-Javed, et al.
Oncoimmunology|February 13, 2025
The pancreatic tumor microenvironment of treatment-naïve patients causes a functional shift in γδ T cells, impairing their anti-tumoral defenseElena Lo Presti, Francesca Cupaioli, Daniela Scimeca, et al.
Nature Biotechnology|September 7, 2023
Genotoxic effects of base and prime editing in human hematopoietic stem cellsMartina Fiumara, Samuele Ferrari, Attya Omer-Javed, et al.
Nature Communications|May 8, 2026
Simultaneous orthogonal cell engineering by a single CRISPR-Cas9 polyfunctional editorDeborah Cipria, Tania Baccega, Miriana Rizzo, et al.
The Journal of Experimental Medicine|July 2, 2024
A novel STING variant triggers endothelial toxicity and SAVI diseaseErika Valeri, Sara Breggion, Federica Barzaghi, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|August 21, 2024
Transcriptomic analysis of BM-MSCs identified EGR1 as a transcription factor to fully exploit their therapeutic potentialLudovica Santi, Stefano Beretta, Margherita Berti, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 12, 2022
Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCsStefania Crippa, Anastasia Conti, Valentina Vavassori, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 19, 2022
Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCsStefania Crippa, Anastasia Conti, Valentina Vavassori, et al.
Frontiers in Immunology|June 18, 2021
Premature Senescence and Increased Oxidative Stress in the Thymus of Down Syndrome PatientsGenni Enza Marcovecchio, Francesca Ferrua, Elena Fontana, et al.
Cell Stem Cell|March 26, 2019
Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage ResponseGiulia Schiroli, Anastasia Conti, Samuele Ferrari, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Nature Biotechnology|January 25, 2024
Author Correction: Genotoxic effects of base and prime editing in human hematopoietic stem cellsMartina Fiumara, Samuele Ferrari, Attya Omer-Javed, et al.
Oncoimmunology|February 13, 2025
The pancreatic tumor microenvironment of treatment-naïve patients causes a functional shift in γδ T cells, impairing their anti-tumoral defenseElena Lo Presti, Francesca Cupaioli, Daniela Scimeca, et al.
Nature Biotechnology|September 7, 2023
Genotoxic effects of base and prime editing in human hematopoietic stem cellsMartina Fiumara, Samuele Ferrari, Attya Omer-Javed, et al.
Nature Communications|May 8, 2026
Simultaneous orthogonal cell engineering by a single CRISPR-Cas9 polyfunctional editorDeborah Cipria, Tania Baccega, Miriana Rizzo, et al.
The Journal of Experimental Medicine|July 2, 2024
A novel STING variant triggers endothelial toxicity and SAVI diseaseErika Valeri, Sara Breggion, Federica Barzaghi, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|August 21, 2024
Transcriptomic analysis of BM-MSCs identified EGR1 as a transcription factor to fully exploit their therapeutic potentialLudovica Santi, Stefano Beretta, Margherita Berti, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 12, 2022
Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCsStefania Crippa, Anastasia Conti, Valentina Vavassori, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 19, 2022
Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCsStefania Crippa, Anastasia Conti, Valentina Vavassori, et al.
Frontiers in Immunology|June 18, 2021
Premature Senescence and Increased Oxidative Stress in the Thymus of Down Syndrome PatientsGenni Enza Marcovecchio, Francesca Ferrua, Elena Fontana, et al.
Cell Stem Cell|March 26, 2019
Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage ResponseGiulia Schiroli, Anastasia Conti, Samuele Ferrari, et al.
Pageof 13